Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Photo not available

Julie Rhie, Ph.D., R.Ph.

Senior Regulatory Affairs Scientist
Pharmacologist
Regulatory Affairs Branch
NCI DCTD Cancer Therapy Evaluation Program
240-276-6065
|
rhiej@ctep.nci.nih.gov

Dr. Julie Rhie joined the Regulatory Affairs Branch in 2001. Her roles include acting as a regulatory liaison for CTEP with the FDA, and as an internal regulatory policy advisor. She oversees a drug development support contract that includes the drafting of INDs, safety reporting and medical writing. 

Prior to joining RAB, Dr. Rhie was a Pharmacologist with the Developmental Therapeutics Program, DCTD, NCI and an NIGMS Pharmacology Research Associate Fellow where she was involved in research and regulatory review at CBER, FDA. 

She graduated from the Rutgers College of Pharmacy and is a licensed pharmacist. Dr. Rhie received her Doctorate in Pharmaceutics from the University of Michigan specializing in oral absorption pharmacokinetics.  

  • Updated:
Email